Moderately to Severely Immunocompromised People and COVID-19 Vaccines

This message includes updates on the COVID-19 response from CDC. This is a rapidly evolving situation and information will be updated as it becomes available.

Received this email from a friend? Sign up now

View this email in your web browser

September 14, 2021 This message includes updates on the COVID-19 response from CDC. The COVID-19 Outbreak is a rapidly evolving situation and information will be updated as it becomes available.

COVID-19 Vaccines for Moderately to Severely Immunocompromised People People with moderately to severely compromised immune systems are especially vulnerable to COVID-19 and may not build the same level of immunity to 2-dose vaccine series compared to people who are not immunocompromised. CDC recommends that people with moderately to severely compromised immune systems receive an additional dose of mRNA COVID-19 vaccine at least 28 days after a second dose of Pfizer-BioNTech COVID-19 or Moderna COVID-19 vaccine. This additional dose is intended to improve the response of people who are immunocompromised to their initial vaccine series. Although CDC does not recommend additional doses or booster shots for any other population at this time, HHS has announced a plan to begin offering COVID-19 vaccine booster shots this fall

Learn More

COVID-19 Prevention in Schools As a parent or caregiver, you can and should learn more about how your school is using the CDC guidance to help slow the spread of COVID-19. Some questions you can ask your school to learn more about their COVID-19 precautions include: What prevention strategies are you currently using at school? How and when are you updating your protocols for COVID-19? Will you offer COVID-19 vaccination at the school? Are you requiring teachers, staff, or students ages 12 and older to be vaccinated against COVID-19? Will you be providing screening testing regularly? It is also extremely important right now to teach and reinforce healthy behaviors for your children. Talk to them about the importance of masking, distancing, and frequent handwashing so that they can make choices that help keep them safer at school.

Learn More

Types of Masks and Respirators The National Institute for Occupational Safety and Health (NIOSH) approves many types of filtering facepiece respirators. The most widely available are N95, but other types (N99, N100, P95, P99, P100, R95, R99, and R100) offer the same or better protection as an N95. When supplies are available, individuals may choose to use a basic disposable N95 respirator for personal use, instead of a mask, in some situations. CDC recommends that special N95 respirators labeled as “surgical” or “medical” should be prioritized for healthcare providers. NIOSH and OSHA have developed a video demonstrating how to perform a user seal check and how to properly put on and take off a respirator.

Learn More

COVID Data Tracker Weekly Review The United States recently surpassed 40 million total COVID-19 cases. Some people experience post-COVID conditions or longer-term health conditions that can last weeks, even months. COVID-19 vaccines are the best way to prevent severe illness and death from COVID-19. Get vaccinated as soon as you can. Check out the COVID Data Tracker Weekly Review. Learn More Subscribe

Coronavirus Disease 2019 (COVID-19) in the U.S.

September 14, 2021 US states, territories, and District of Columbia have reported 41,001,157 cases of COVID-19 in the United States. CDC provides updated U.S. case information online daily. In addition to cases, deaths, and laboratory testing, CDC's COVID Data Tracker now has a Vaccinations tab to track distribution of COVID-19 vaccines in your state.

U.S. Cases

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe